# CTO Simulation Enrichment: High-Fidelity & Professional Standards

This document outlines the strategy for transforming the CTO simulation into a "substantial" demonstration of the ClawGraph Super-Orchestrator's capabilities.

## 1. Core Mandate: "Substance at Any Cost"
- **High Fidelity**: Do not compromise on detail. If a task requires deep regulatory knowledge, use research tools to acquire it.
- **Token Efficiency**: Disregard token costs for this phase. Prioritize high-fidelity reasoning and complex artifact generation and discovery.
- **Research Requirements**: The implementer MUST use web search to:
    - Find actual FDA/EMA guidance documents, form templates, and clinical report structures.
    - Download relevant PDFs/templates or request the user to provide specific proprietary documents.
    - Synthesize "interesting" tasks that reflect real-world pharmaceutical complexity.

## 2. Example Professional Directives (Baseline)
These represent the "middle ground" of being substantial but readable for a demo:
1. **NDA Admin Package**: "Assemble the **NDA Admin Package**, focusing on the FDA 356h Form and Regulatory Cover Letter."
2. **CMC Quality Summary**: "Synthesize the **CMC Quality Summary** based on latest Drug Substance stability data (ICH M4Q sections)."
3. **Clinical Safety Dossier**: "Generate the **Clinical Safety & Efficacy Dossier**, distilling clinical trial efficacy and safety milestones, including EASI scores and p-values."

## 3. High-Fidelity Research Tasks
- **Task 1: Form 356h Specialization**: Find the latest PDF template for FDA Form 356h. Research the exact fields required for "Chemistry, Manufacturing, and Controls" references.
- **Task 2: ICH M4Q Structure**: Search for "ICH M4Q Granularity Map" to understand exactly how Module 2.3 (QOS) links to Module 3 documents.
- **Task 3: Clinical Narrative Standards**: Find examples of "Patient Narratives for Serious Adverse Events" to improve the Clinical Ops domain's output substance.

## 4. Implementation Directives
- **Search First**: Before generating any regulatory artifact, search for a real-world example of that document.
- **Artifact Depth**: Every generated markdown file should include at least 5-7 specific sub-headers following international regulatory standards (e.g., 3.2.P.1, 3.2.P.2).
- **Intervention Depth**: When acting as the Super-Orchestrator, use "Audit Node" to check if the generated text matches the researched standards.

## 5. High-Fidelity Input/Output Mapping (Ground Truth)

This section maps the enriched seed documents (inputs) to the expected high-fidelity node outputs.

### A. Clinical Domain
- **Input Seed**: `protocol_v1.md` (N=450, EASI-75 primary endpoint).
- **Processing Node**: `protocol_benchmark` & `scribe_visit`.
- **Expected Output**: `narration_scribe_output.md` following **ICH E3** (Section 12.3.2) demographics and chronological clinical course.

### B. CMC Domain
- **Input Seed**: `stability_test_report_q1.md` (Batch CG-DS-2026-X1, impurity drift logs).
- **Processing Node**: `author_mod3` & `manage_stability`.
- **Expected Output**: `mod3_author_output.md` following **ICH M4Q** DMCS taxonomy with explicit drift analysis (NMT 0.15% limits).

### C. Regulatory Admin Domain
- **Input Seed**: `reg_sources/FDA-356h_...pdf` & `source_docs_v1.md`.
- **Processing Node**: `publish_submission`.
- **Expected Output**: `submission_publisher_output.md` containing **FDA Form 356h** Field 28 (Establishment) and Field 30 (Cross-references) matrices.

### D. Safety & Efficacy Domain
- **Input Seed**: `patient_sync_raw.csv` (12-subject raw dataset).
- **Processing Node**: `generate_safety_dossier`.
- **Expected Output**: `clinical_safety_dossier_output.md` distilling **EASI-75 achievement stats** (p < 0.001) and SAE causality assessments.
